Últimas noticias sobre Riot Platforms (NASDAQ:RIOT) Bolsa

RIOT PLATFORMS INC

Riot Platforms

Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining and Engineering. The Bitcoin Mining segment generates revenue from the Bitcoin the Company earns through its Bitcoin Mining activities. The Engineering segment generates revenue through customer contracts for custom engineered electrical products. It generates the majority of its revenue from the Bitcoin Mining segment.

Apex,,North,Carolina,-,May,7,2025:,Strategy,Microstrategy,Mstr

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

$BTC

MARA

MSTR

MTPLF

RIOT

Strategy (NASDAQ:MSTR), una importante compañía institucional que posee una gran cantidad de Bitcoin (CRYPTO: BTC), ha ampliado sus reservas de criptomonedas esta semana con una nueva adquisición de 6220 BTC.

Strategy amplía sus reservas y ya posee más de 600.000 bitcoins

Stuttgart,,Germany,-,08-24-2023:,Person,Holding,Cellphone,With,Website,Of

Markets

La principal empresa de minería de Bitcoin (CRYPTO: BTC), Riot Platforms Inc. (NASDAQ:RIOT), ha mostrado un sólido desempeño en las últimas semanas, a pesar de que el movimiento del precio de la criptomoneda más grande del 

Riot Platforms crece un 76 % en producción y supera la quietud de Bitcoin

Golden,Ray,Of,Light,Illuminate,A,Bitcoin,,The,Money,Of

CLSK

COIN

GLXY

La firma japonesa de inversión Metaplanet Inc. (OTC:MTPLF) superó a un par de empresas que cotizan en Nasdaq para convertirse en el quinto mayor tenedor corporativo de Bitcoin (CRYPTO: BTC) el lunes.

Metaplanet compra 1.005 Bitcoin y escala al quinto puesto de empresas con más BTC

Riot Platforms Inc

SRPT

Trading Halt: Halt status updated at 5:35:00 PM ET: Quotation Resumption: News and Resumption Times

<a href="https://www.bloomberg.com/news/articles/2025-07-28/harley-davidson-said-to-near-financing-unit-deal-with-pimco-kkr?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-07-28/harley-davidson-said-to-near-financing-unit-deal-with-pimco-kkr?embedded-checkout=true</a>

General

'Harley Davidson Nears Financing Unit Deal With Pimco, KKR'- Bloomberg

Telefonica Brasil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIV#NYSE">VIV</a>) reported quarterly earnings of $0.15 per share which missed the analyst consensus estimate of $0.16 by 6.25 percent. This is a 7.14 percent increase over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $2.552 billion which missed the analyst consensus estimate of $2.590 billion by 1.47 percent. This is a 2.78 percent decrease over sales of $2.625 billion the same period last year.

Earnings

Earnings Misses

Telefonica Brasil Q2 EPS $0.15 Misses $0.16 Estimate, Sales $2.552B Miss $2.590B Estimate

Murphy USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUSA#NYSE">MUSA</a>) has outperformed the market over the past 10 years by 11.29% on an annualized basis producing an average annual return of 23.06%. Currently, Murphy USA has a market capitalization of $8.32 billion. 
Buying $1000 In MUSA: If an investor had bought $1000 of MUSA stock 10 years ago, it would be worth $7,943.52 today based on a price of $420.53 for MUSA at the time of writing.
<h3>Murphy USA's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753738216_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

MUSA

Here's How Much $1000 Invested In Murphy USA 10 Years Ago Would Be Worth Today

Scotiabank analyst Greg Harrison maintains Agios Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGIO#NASDAQ">AGIO</a>) with a Sector Outperform and lowers the price target from $71 to $65.

Price Target

Analyst Ratings

AGIO

Scotiabank Maintains Sector Outperform on Agios Pharmaceuticals, Lowers Price Target to $65

Scotiabank analyst Hector Maya initiates coverage on MercadoLibre (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) with a Sector Outperform rating and announces Price Target of $3500.

Initiation

MELI

Scotiabank Initiates Coverage On MercadoLibre with Sector Outperform Rating, Announces Price Target of $3500

Tilray Brands Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) reported fourth-quarter financial results for fiscal 2025 after the market close on Monday. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/07/g46673944/tilray-brands-reports-fourth-quarter-and-fiscal-2025-financial-results">of the report</a>.
TLFY stock is volatile after hours. <a href="https://www.benzinga.com/quote/TLRY">Check the latest price here</a>.
Q4 Earnings: Tilray reported fiscal fourth-quarter revenue of $224.53 million, missing analyst <a href="http://benzinga.com/quote/TLRY/earnings">estimates</a> of $250.41 million, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. The cannabis company reported fourth-quarter adjusted earnings of two cents per share, beating estimates for a loss of three cents per share.
Total revenue was down roughly 2% on a year-over-year basis. Here&#8217;s a breakdown of revenue by category.
<ul class="wp-block-list">
<li>Cannabis: $67.8 million, down from $71.9 million year-over-year</li>
</ul>
<ul class="wp-block-list">
<li>Beverage: $65.6 million, down from $76.7 million year-over-year</li>
</ul>
<ul class="wp-block-list">
<li>Distribution: $74.1 million, up from $65.6 million&nbsp;year-over-year</li>
</ul>
<ul class="wp-block-list">
<li>Wellness: $17 million, up from $15.7 million year-over-year</li>
</ul>
Tilray ended the period with $256 million in cash and marketable securities.
&#8220;Looking ahead to fiscal year 2026, we see key growth opportunities in cannabis, beverage and wellness,&#8221; said Irwin Simon, chairman and CEO of Tilray Brands.
&#8220;Our global infrastructure and international distribution network position us to lead as the global cannabis market expands. Our commitment to innovation across our portfolio of brands, including our AI initiatives, differentiates Tilray from the broader competitive landscape.&#8221;
Tilray noted that it&#8217;s implementing AI across its businesses to optimize processes, achieve substantial improvements and advance business objectives.&nbsp;
Tilray guided for fiscal 2026 adjusted EBITDA of $62 million to $72 million, representing growth of 13% to 31% year-over-year.
TLRY Price Action:&nbsp;<a href="https://www.benzinga.com/quote/TLRY" target="_blank" rel="noreferrer noopener">Tilray shares</a>&nbsp;were down 8.53% after hours, trading at approximately 69 cents at the time of publication Monday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/content/46431448/tilray-shares-blazing-whats-behind-the-55-rally-this-month">Tilray Shares Blazing: What&#8217;s Behind the 55% Rally This Month?</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/Below_the_Sky">Below the Sky</a>/Shutterstock.com

Cannabis

Guidance

After-Hours Center

Movers

TLRY

Tilray Misses Q4 Revenue, Beats EPS Estimates, Shares Slide

CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLGN#NASDAQ">QLGN</a>) (the "Company") received two different communications from the staff of the Nasdaq Listing Qualifications office of the Nasdaq Stock Market, LLC. The Company received the first notice from the Nasdaq Listings Qualifications office of the Nasdaq Stock Market LLC on July 23, 2025, informing the Company that as reflected in the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 filed with the SEC on July 21, 2025, the Company failed to comply with the $2.5 million stockholder's equity required under Nasdaq Rule 5550(b)(1) (the "Equity Rule") or any alternative standard under Nasdaq 5550(b).
On June 24, 2025, the Company received a second communication from the Office of the General Counsel of Nasdaq, confirming that Nasdaq had reviewed and accepted the Company's request for an extension with respect to three specific items. First, the Company was required to file its Quarterly Report on Form 10-Q for the period ended March 31, 2025, by July 21, 2025 — which Nasdaq confirmed has been completed. Second, the Company was required to regain compliance with the minimum stockholders' equity requirement (the "Equity Rule") by July 28, 2025 — which it has achieved through the successful closing of a $4.5 million private placement of Series A-3 Preferred Stock, prior to customary fees and expenses, as announced earlier today. Third, the Company was required to demonstrate a plan to maintain compliance with all applicable continued listing standards — which Nasdaq acknowledged it has received, including the Company's plan to maintain compliance with the stockholders' equity requirement over the next 12 months.
The Company is making every effort to maintain its current Nasdaq listing and will continue to take all necessary actions toward that goal. However, there can be no assurance that the Company will be able to maintain compliance with Nasdaq's continued listing requirements.
The Company intends to file a Current Report on Form 8-K with the Securities and Exchange Commission later today, which will include a pro forma balance sheet reflecting stockholders' equity in compliance with the applicable requirements, assuming the private placement described above had closed as of March 31, 2025.
About Qualigen Therapeutics, Inc.
Qualigen Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLGN#NASDAQ">QLGN</a>) is a clinical-stage biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases. The Company's pipeline includes QN-302, a selective G-quadruplex inhibitor targeting various tumor types including pancreatic cancer; QN-247, a nucleolin-targeting compound for hematologic malignancies; and a family of small-molecule RAS oncogene protein-protein interaction inhibitors. Each of these programs is designed to address areas of high unmet medical need, with the potential for orphan drug designation. Qualigen is committed to advancing its therapeutic pipeline to improve patient outcomes and create long-term value for shareholders.

Qualigen Therapeutics, Inc. - Common Stock

QLGN

Qualigen Therapeutics Provides Update On NASDAQ Communications and Continued Listing Status; Company Is Making Every Effort To Maintain Its Current Nasdaq Listing And Will Continue To Take All Necessary Actions Toward That Goal; However, There Can Be No Assurance That The Company Will Be Able To Maintain Compliance With Nasdaq's Continued Listing Requirement

Citigroup analyst Andrew Kaplowitz maintains Quanta Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWR#NYSE">PWR</a>) with a Buy and raises the price target from $432 to $492.

Citigroup Maintains Buy on Quanta Services, Raises Price Target to $492

APLS

Trading Halt: Halted at 5:18:12 p.m. ET - Trading Halt: Halt News Pending

Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) has outperformed the market over the past 10 years by 2.51% on an annualized basis producing an average annual return of 14.27%. Currently, Texas Instruments has a market capitalization of $171.76 billion. 
Buying $1000 In TXN: If an investor had bought $1000 of TXN stock 10 years ago, it would be worth $3,778.20 today based on a price of $188.95 for TXN at the time of writing.
<h3>Texas Instruments's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753737364_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

Leerink Partners analyst Andrew Berens maintains Celcuity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELC#NASDAQ">CELC</a>) with a Outperform and raises the price target from $28 to $60.

CELC

Leerink Partners Maintains Outperform on Celcuity, Raises Price Target to $60

Ranger Energy Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNGR#NYSE">RNGR</a>) ("Ranger" or the "Company") today announced the development of the industry's first Hybrid Double Electric Workover Rig. This innovation represents a major leap forward in improving operating efficiency, maintaining safe operations and reducing emissions.
Construction of the hybrid rigs involves the conversion of an existing Taylor rig design uniquely available to Ranger, allowing electrification of the existing high-specification rig fleet at a cost that is meaningfully below the estimated cost of a newbuild electric rig. The ECHO rig leverages proven industrial electrification technologies adapted from outside the energy sector, delivering a differentiated solution to the market. Two ECHO rigs are under construction with delivery expected in the third quarter of 2025.

RNGR

Ranger Energy Unveils Industry's First Hybrid Double Electric Workover Rig, With Two Units Set For Q3 2025 Delivery

ENVX

Enovix Stock Trades Above $10.50 for 5 Days, Triggering Potential Early Warrant Expiration As Soon As August 19, 2025

Metsera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSR#NASDAQ">MTSR</a>) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.64) by 3.13 percent. This is a 64.52 percent increase over losses of $(1.86) per share from the same period last year.

MTSR

Metsera Q2 EPS $(0.66) Misses $(0.64) Estimate

National Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRC#NASDAQ">NRC</a>) reported quarterly losses of $(0.01) per share. This is a 103.85 percent decrease over earnings of $0.26 per share from the same period last year. The company reported $34.038 million in sales this quarter. This is a 2.81 percent decrease over sales of $35.021 million the same period last year.

National Research Q2 EPS $(0.01) Down From $0.26 YoY, Sales $34.038M Down From $35.021M YoY

German American Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GABC#NASDAQ">GABC</a>) reported quarterly earnings of $0.86 per share which beat the analyst consensus estimate of $0.84 by 2.75 percent. This is a 24.64 percent increase over earnings of $0.69 per share from the same period last year. The company reported quarterly sales of $89.888 million which missed the analyst consensus estimate of $89.901 million by 0.01 percent. This is a 38.52 percent increase over sales of $64.894 million the same period last year.

Earnings Beats

GABC

German American Bancorp Q2 Adj. EPS $0.86 Beats $0.84 Estimate, Sales $89.888M Miss $89.901M Estimate

<h3>Gainers</h3>
<ul>
<li>PetMed Express (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PETS#NASDAQ">PETS</a>) stock increased by 8.7% to $3.86 during Monday's after-market session. The company's market cap stands at $77.8 million. </li>
<li>Birks Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BGI#AMEX">BGI</a>) stock rose 7.61% to $0.88. The company's market cap stands at $16.8 million. As per the press release, FY earnings came out yesterday. </li>
<li>Garrett Motion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTX#NASDAQ">GTX</a>) shares moved upwards by 6.19% to $13.88. The company's market cap stands at $2.6 billion. As per the news, the Q2 earnings report came out 2 days ago. </li>
<li>Interactive Strength (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNR#NASDAQ">TRNR</a>) stock moved upwards by 5.45% to $5.61. The company's market cap stands at $8.4 million. </li>
<li>Pitanium (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTNM#NASDAQ">PTNM</a>) shares moved upwards by 4.51% to $1.85. The company's market cap stands at $43.0 million. </li>
<li>Connexa Sports Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YYAI#NASDAQ">YYAI</a>) shares moved upwards by 3.88% to $4.46. The company's market cap stands at $45.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Leslies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) stock declined by 13.8% to $0.55 during Monday's after-market session. The company's market cap stands at $110.4 million. </li>
<li>Whirlpool (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHR#NYSE">WHR</a>) stock decreased by 12.69% to $85.49. The company's market cap stands at $5.5 billion. The company's, Q2 earnings came out today. </li>
<li>Jiade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JDZG#NASDAQ">JDZG</a>) stock declined by 4.93% to $2.51. The company's market cap stands at $8.2 million. </li>
<li>Newton Golf (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTG#NASDAQ">NWTG</a>) shares declined by 4.67% to $1.84. The market value of their outstanding shares is at $8.0 million. </li>
<li>BT Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBD#NASDAQ">BTBD</a>) stock fell 4.61% to $1.45. The company's market cap stands at $7.8 million. </li>
<li>Sonder Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOND#NASDAQ">SOND</a>) stock declined by 3.9% to $2.22. The market value of their outstanding shares is at $25.9 million. As per the press release, Q4 earnings came out 3 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BTBD

JDZG

LESL

NWTG

PETS

PTNM

SOND

TRNR

Connexa Sports Technologies Inc. - Common Stock

YYAI

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Adaptimmune Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAP#NASDAQ">ADAP</a>) shares rose 17.0% to $0.12 during Monday's after-market session. The company's market cap stands at $91.9 million. </li>
<li>Milestone Scientific (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MLSS#AMEX">MLSS</a>) shares moved upwards by 13.54% to $0.55. The company's market cap stands at $46.3 million. </li>
<li>Adial Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADIL#NASDAQ">ADIL</a>) stock rose 10.9% to $0.7. The market value of their outstanding shares is at $8.1 million. </li>
<li>PTC Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTCT#NASDAQ">PTCT</a>) stock moved upwards by 8.25% to $48.0. The company's market cap stands at $3.5 billion. </li>
<li>Aclarion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACON#NASDAQ">ACON</a>) stock increased by 6.88% to $8.38. The company's market cap stands at $4.3 million. </li>
<li>Maze Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAZE#NASDAQ">MAZE</a>) stock increased by 6.62% to $17.37. The company's market cap stands at $736.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>180 Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNF#NASDAQ">ATNF</a>) shares decreased by 18.9% to $2.36 during Monday's after-market session. The company's market cap stands at $18.1 million. As per the press release, Q2 earnings came out 3 days ago. </li>
<li>Exelixis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) shares decreased by 13.27% to $38.5. The market value of their outstanding shares is at $12.4 billion. As per the press release, Q2 earnings came out today. </li>
<li>Metsera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSR#NASDAQ">MTSR</a>) shares declined by 8.7% to $36.0. The market value of their outstanding shares is at $4.2 billion. </li>
<li>Neumora Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRA#NASDAQ">NMRA</a>) stock declined by 6.61% to $2.12. The market value of their outstanding shares is at $380.1 million. </li>
<li>Eledon Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELDN#NASDAQ">ELDN</a>) shares fell 6.2% to $3.03. The company's market cap stands at $216.7 million. </li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) shares decreased by 5.8% to $4.0. The company's market cap stands at $58.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACON

ADAP

ADIL

ATNF

ELDN

EXEL

MAZE

MLSS

NMRA

PTCT

12 Health Care Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>FGI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGI#NASDAQ">FGI</a>) stock rose 6.8% to $0.76 during Monday's after-market session. The market value of their outstanding shares is at $7.2 million. </li>
<li>Zeo Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEO#NASDAQ">ZEO</a>) shares rose 5.81% to $2.73. The company's market cap stands at $58.6 million. </li>
<li>MingZhu Logistics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) stock rose 5.14% to $1.02. The company's market cap stands at $77.4 million. </li>
<li>VCI Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCIG#NASDAQ">VCIG</a>) shares increased by 5.09% to $1.03. The market value of their outstanding shares is at $5.1 million. </li>
<li>Dragonfly Energy Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFLI#NASDAQ">DFLI</a>) stock moved upwards by 5.07% to $0.39. The company's market cap stands at $3.8 million. </li>
<li>Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) shares rose 4.74% to $199.0. The company's market cap stands at $10.9 billion. As per the press release, Q2 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) shares decreased by 22.7% to $0.07 during Monday's after-market session. The market value of their outstanding shares is at $2.9 million. </li>
<li>VisionWave Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VWAV#NASDAQ">VWAV</a>) stock declined by 19.64% to $8.84. The market value of their outstanding shares is at $33.5 million. </li>
<li>Kforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFRC#NYSE">KFRC</a>) shares declined by 10.47% to $42.0. The company's market cap stands at $865.3 million. As per the news, the Q2 earnings report came out today. </li>
<li>CEA Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VAPE#NASDAQ">VAPE</a>) shares decreased by 5.95% to $54.21. The market value of their outstanding shares is at $7.4 million. </li>
<li>Graphjet Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) shares declined by 5.51% to $0.13. The market value of their outstanding shares is at $14.6 million. </li>
<li>Clean Energy Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETY#NASDAQ">CETY</a>) shares declined by 5.5% to $0.22. The market value of their outstanding shares is at $14.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CETY

DFLI

KFRC

VAPE

VCIG

VWAV

WLGS

YGMZ

12 Industrials Stocks Moving In Monday's After-Market Session

Small Cap

Press Releases

Riot Platforms Announces Hiring of Jonathan Gibbs as Chief Data Center Officer to Lead Data Center Platform

Riot Announces May 2025 Production and Operations Updates

RIOT PLATFORMS, INC. REPORTS BENEFICIAL OWNERSHIP OF 14.3% IN BITFARMS LTD.

RIOT PLATFORMS, INC. REPORTS BENEFICIAL OWNERSHIP OF 12.3% IN BITFARMS LTD.

Riot Announces June 2025 Production and Operations Updates

Bitcoin Acquisitions Booming as Companies Tap into Coinbase Credit Facilities Opportunity

RIOT PLATFORMS, INC. REPORTS BENEFICIAL OWNERSHIP OF 10.29% IN BITFARMS LTD.

RIOT PLATFORMS, INC. REPORTS BENEFICIAL OWNERSHIP OF 9.85% IN BITFARMS LTD.

Riot Announces Second Quarter 2025 Earnings Conference Call

Global Blockchain Artificial Intelligence Market Size Estimated to Reach $4.33 Billion By 2034

CSE:ISTK

HOOD

ISTKF

KULR

TSX:GLXY

ACI Worldwide

C3.ai

AvePoint

BILL Holdings

BitMine Immersion Technologies, Inc. Common Stock

BitMine Immersion Techs

CCC Intelligent Solutions Holdings Inc. - Common Stock

CCC Intelligent Solutions

Core Scientific

Clearwater Analytics Holdings, Inc. Class A Common Stock

Clearwater Analytics Hldg

Dropbox

Freshworks

InterDigital

Informatica

IREN

Life360

MARA Holdings

Ncino

Pony AI Inc. - American Depositary Shares

Pony AI

D-Wave Quantum

Q2 Holdings

SoundHound AI, Inc. - Class A Common Stock

SoundHound AI

SPS Commerce

Vertex

Workiva

Zeta Global Holdings Corp. Class A Common Stock

Zeta Global Holdings

JP Morgan

Piper Sandler

Needham

Roth MKM

Cantor Fitzgerald

Riot Blockchain

Screenshot 2025-02-14 at 11.00.11 AM

FUFU

How BitFuFu&#39;s 1GW Global Capacity Expansion Plan Can Help Move Crypto Into A New Landscape

Screenshot 2024-11-15 at 7.42.11 PM

BTDR

BitFuFu Posts Double-Digit Third Quarter Revenue Growth In A Challenging Market

Untitled design - 2024-08-30T174008.310

BITF

BitFuFu Posts 70% Revenue Growth And Outlines Strategic Expansion – Company Expects Continued Growth Amid Market Volatility

Screenshot 2024-06-26 at 5.30.28 PM

NVDA

Three Bitcoin Players You May Want To Watch In The Next Potential Bull Cycle

Screenshot 2024-05-29 at 5.42.06 PM

BitFuFu Q1 Earnings: Adjusted EBITDA Up 430.9% To $49.4 Million On Revenue Growth Of 149%, Cash Position Rises To $163.7 Million

Screenshot 2024-04-12 at 5.28.51 PM

Bitdeer Releases Full-Year Results For 2023 – Revenue Up And Forecast For Continued Growth

Screenshot 2024-03-13 at 5.41.37 PM

Bitdeer Creates First-Generation Bitcoin Mining Chip In Major Step To Becoming The First Fully Integrated Miner

Comments

Riot Platforms

Noticias

Últimas noticias sobre Riot Platforms (NASDAQ:RIOT) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL